Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Intangible Assets

As of the most recent data (June 2026), BLACR shows a intangible assets of $130M. That compares with $160M in the prior-year period — down 13.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLACR's intangible assets is now $130M (was $160M) — a 13.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is outperforming or lagging.

Tracking BLACR's intangible assets over time shows whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is scaling, shrinking, or reshaping that part of the business. The current reading is $130M That compares with $160M in the prior-year period — down 13.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $130M) with ownership activity and broader fundamentals.